Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DECREASE SSI: Decolonization to Reduce Surgical Site Infection
NCT05586776Phase 4Recruiting
- Sponsor
- University of California, Irvine
- Start
- Jan 2023
- Primary completion
- Jun 2027
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of chlorhexidine, mupirocin in surgical site infection (SSI), sponsored by University of California, Irvine. Started Jan 2023; status: recruiting.
02
Drugs
chlorhexidinemupirocin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05586776.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05586776.